melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
CD2_INSITU_MELANOMA
Extra metadata
List of similar endpoints to
Melanoma in situ
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 490 | 253 | 237 |
| Unadjusted prevalence (%) | 0.19 | 0.17 | 0.21 |
| Mean age at first event (years) | 65.60 | 62.71 | 68.68 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.01 | 1.03 [0.46, 2.30] | 9.5e-1 | 31 |
| 15 years | 0.01 | 1.12 [0.51, 2.46] | 7.7e-1 | 31 |
| 5 years | 0.00 | 1.62 [0.72, 3.62] | 2.4e-1 | 16 |
| 1 year | - | - | - | - |
Index endpoint: CD2_INSITU_MELANOMA – Melanoma in situ
GWS hits: 0
before Melanoma in situ
after Melanoma in situ
Loading survival analyses plot
Loading survival analyses table